product-development

Pharmaceutical Product Development

At United Science, our pharmaceutical experts guide your company through product development using the principles of Quality by Design (QbD). Product Development means target product profiles, Quality by Design (QbD) process guidance, and prototypes. Our risk-based approach ensures efficient, consistent, and cost-effective processes to develop and manufacture patient-focused products that meet regulatory, safety, and quality requirements.

United Science provides a forward-looking approach to the product development lifecycle, leveraging industry-leading technologies and breakthrough innovations to position products for commercial success. Our team has developed a toolkit utilizing United Science’s project management, development, and quality management tools tailored to your organizational and project needs to ensure efficient solutions to achieve your goals. Our knowledge of the pharmaceutical industry enables us to handle any project in these areas. Contact United Science about your product development project, and an expert will get back to you as soon as possible.

What product development covers

Pharmaceutical product development at United Science is the work of deciding what the product should be and proving that a formulation can deliver it. It answers questions about the drug product itself: dose, dosage form, excipients, release behavior, stability, and how a patient will take it. How the product is then made at scale is handled by our process development team, and the two groups work from the same data.

Our approach, step by step

1. Target product profile. We start by writing down what the finished product must do: route of administration, dose strength, dosage form, shelf life, and patient needs such as ease of swallowing or taste. The target product profile becomes the reference for every later decision.

2. Quality target product profile and CQAs. From the target profile we identify the critical quality attributes, such as assay, content uniformity, dissolution, impurities, and stability, that the product must meet to be safe and effective.

3. Pre-formulation and risk assessment. We study the active ingredient’s properties and use a risk-based approach to decide which formulation and material variables are most likely to affect the CQAs. This keeps experimental work focused on the variables that matter.

4. Formulation and prototypes. Our scientists build and test prototype formulations, comparing options against the target profile. Depending on the product, this can include softgels, solid dosage forms, liquid dosage forms, or bioavailable formulations where increased bioavailability is a design goal.

5. Analytical support. Formulation decisions depend on reliable data. Our analytical development laboratory develops the methods used to measure each prototype and to run stability studies.

6. Transfer to process development and manufacturing. When a formulation is selected, we hand it to process development with the knowledge, specifications, and data gathered so far. Continuity of the team is a large part of how we avoid rework at this stage.

Quality by Design in practice

QbD is a method, not a slogan. In practice it means linking each formulation and process choice to its effect on quality, recording why choices were made, and building a design space that gives you flexibility later. That record also supports your CMC documentation, because the reasoning behind the formulation is already written down.

Who this service is for

This service suits companies developing a new drug product, reformulating an existing one to a new dosage form, or moving a natural-product or botanical ingredient into a pharmaceutical format. It also suits teams that have a promising molecule but no in-house formulation group.

Frequently asked questions

How is product development different from process development?

Product development defines the formulation and proves it meets the target product profile. Process development works out how to make that formulation consistently at clinical and commercial scale.

Can you work with an active ingredient we supply?

Yes. Many projects start with a client-supplied API. We can also support API work through our API and botanical substance services.

Do you make clinical trial material?

Yes. We make softgels, hard capsules, tablets, liquids, and sprays in house at our FDA-registered facility in Osceola, Wisconsin, and can supply clinical material in these forms.

Which dosage forms can you develop?

We develop softgels, solid dosage forms, liquid dosage forms, and bioavailable formulations. Contact us to discuss a specific format.

Contact Us

Schedule a Call

Feel free to reach out to us for any inquiries or to schedule a call. Our team is here to assist you every step of the way. Whether you have questions about our services, want to discuss your project, or need a quote, we’re just a call away. Your journey to innovative solutions starts here.